0

sTNF-RI human

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATIAR42413754
MDL NumberMFCD01324859
Descriptionrecombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC)
Assay≥98% (HPLC); ≥98% (SDS-PAGE)
Formlyophilized
Impurity Contentendotoxin, tested
Size20μG
Storage Conditions−20°C
1

Design of PEGylated Soluble Tumor Necrosis Factor Receptor Type I (PEG sTNF-RI) for Chronic Inflammatory Diseases

Carl K Edwards 3rd, Steven W Martin, James Seely, Olaf Kinstler, Scott Buckel, Alison M Bendele, Mary Ellen Cosenza, Ulrich Feige, Tadahiko Kohno

Adv Drug Deliv Rev. 2003 Sep 26;55(10):1315-36.

PMID: 14499710

1

Elevated Serum Levels of TNF-alpha, sTNF-RI and sTNF-RII in Murine Schistosomiasis Correlate With Schistosome Oviposition and Circumoval Granuloma Formation

M A Haseeb, D J Shirazian, J Preis

Cytokine. 2001 Sep 7;15(5):266-9.

PMID: 11594791

1

Human Soluble Tumor Necrosis Factor Receptor I (sTNF-RI) and interleukin-I Receptor Antagonist (IL-I Ra) in Different Stages of Acute Rheumatic Fever

Necil Kütükçüler, Neslihan E Karaca, Betül Y Sözeri, Güldane Koturoğlu, Zafer Kurugöl, Ruhi A Ozyürek, Güzide Aksu

Anadolu Kardiyol Derg. 2008 Apr;8(2):139-42.

PMID: 18400635

1

PEGylated Recombinant Human Soluble Tumour Necrosis Factor Receptor Type I (r-Hu-sTNF-RI): Novel High Affinity TNF Receptor Designed for Chronic Inflammatory Diseases

C K Edwards 3rd

Ann Rheum Dis. 1999 Nov;58 Suppl 1(Suppl 1):I73-81.

PMID: 10577978

1

TNF-alpha Expression in Painful and Nonpainful Neuropathies

M Empl, S Renaud, B Erne, P Fuhr, A Straube, N Schaeren-Wiemers, A J Steck

Neurology. 2001 May 22;56(10):1371-7.

PMID: 11376190

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Online Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode